STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 72 filers reported holding STOKE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,298,799 | -62.9% | 4,390,558 | 0.0% | 0.36% | -58.9% |
| Q2 2023 | $46,671,632 | +27.6% | 4,390,558 | 0.0% | 0.89% | +16.7% |
| Q1 2023 | $36,573,348 | +2.4% | 4,390,558 | +13.4% | 0.76% | +4.5% |
| Q4 2022 | $35,729,155 | -23.8% | 3,870,981 | +6.0% | 0.73% | -32.6% |
| Q3 2022 | $46,889,000 | -2.8% | 3,651,823 | 0.0% | 1.08% | -13.2% |
| Q2 2022 | $48,241,000 | -37.1% | 3,651,823 | +0.2% | 1.25% | -21.5% |
| Q1 2022 | $76,711,000 | -12.3% | 3,644,248 | 0.0% | 1.59% | +24.4% |
| Q4 2021 | $87,426,000 | -5.7% | 3,644,248 | 0.0% | 1.28% | -8.7% |
| Q3 2021 | $92,710,000 | -24.4% | 3,644,248 | 0.0% | 1.40% | -24.5% |
| Q2 2021 | $122,665,000 | -13.3% | 3,644,248 | 0.0% | 1.85% | -16.2% |
| Q1 2021 | $141,543,000 | -35.5% | 3,644,248 | +2.8% | 2.21% | -40.0% |
| Q4 2020 | $219,495,000 | +84.9% | 3,544,248 | 0.0% | 3.68% | +28.9% |
| Q3 2020 | $118,697,000 | +40.5% | 3,544,248 | 0.0% | 2.86% | +20.3% |
| Q2 2020 | $84,459,000 | +4.1% | 3,544,248 | 0.0% | 2.38% | -32.0% |
| Q1 2020 | $81,163,000 | -19.1% | 3,544,248 | 0.0% | 3.49% | -7.7% |
| Q4 2019 | $100,373,000 | +44.6% | 3,544,248 | +5.6% | 3.79% | -8.2% |
| Q3 2019 | $69,401,000 | -25.0% | 3,355,466 | 0.0% | 4.13% | -16.5% |
| Q2 2019 | $92,570,000 | – | 3,355,466 | – | 4.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $9,991,000 | 2.07% |
| RTW INVESTMENTS, LP | 3,644,248 | $122,665,000 | 1.85% |
| Cormorant Asset Management, LP | 1,278,276 | $43,027,000 | 1.46% |
| Redmile Group, LLC | 2,458,558 | $82,755,000 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 233,135 | $7,847,000 | 0.53% |
| Birchview Capital, LP | 15,000 | $505,000 | 0.30% |
| Perceptive Advisors | 1,343,956 | $45,238,000 | 0.29% |
| GILDER GAGNON HOWE & CO LLC | 1,245,956 | $41,939,000 | 0.21% |
| Artal Group S.A. | 250,000 | $8,415,000 | 0.17% |
| Casdin Capital, LLC | 120,000 | $4,039,000 | 0.10% |